Jiang H et al. |
Control of humoral and cellular immunity-mediated accelerated heart allograft rejection in sensitized rats by low dose FK 506 and splenectomy. |
1992 |
Transpl. Int. |
pmid:14621859
|
Kobayashi N et al. |
Abdominal organ cluster transplantation in pigs and FK506. |
1992 |
Transpl. Int. |
pmid:14621861
|
Metcalfe S et al. |
FK506 and rapamycin: differential sensitivity of human, baboon, cynomolgus monkey, dog and pig lymphocytes. |
1992 |
Transpl. Int. |
pmid:14621863
|
|
Japanese study of kidney transplantation: 1. Results of early phase II study. |
1992 |
Transpl. Int. |
pmid:14621866
|
|
Japanese study of FK 506 on kidney transplantation: 2. Follow-up study of FK 506-treated patients. |
1992 |
Transpl. Int. |
pmid:14621874
|
Chen TS et al. |
Microbial transformation of immunosuppressive compounds. I. Desmethylation of FK506 and immunomycin (FR 900520) by Actinoplanes sp. ATCC 53771. |
1992 |
J. Antibiot. |
pmid:1372307
|
Walpoth B et al. |
Prevention of cardiac allograft rejection by FK506 and rapamycin: assessment by histology and nuclear magnetic resonance. |
1992 |
Transpl. Int. |
pmid:14621877
|
Morisaki M and Arai T |
Identity of immunosuppressant FR-900520 with ascomycin. |
1992 |
J. Antibiot. |
pmid:1372308
|
Asako H et al. |
Reduction of leukocyte adherence and emigration by cyclosporine and L683,590 (FK506) in postcapillary venules. |
1992 |
Transplantation |
pmid:1384191
|
Doi R et al. |
Effects of FK506 on exocrine pancreas in rats. |
1992 |
Pancreas |
pmid:1372739
|
Furukawa H et al. |
The effect of bile duct ligation and bile diversion on FK506 pharmacokinetics in dogs. |
1992 |
Transplantation |
pmid:1373531
|
Sakr M et al. |
Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients. |
1992 |
Transplantation |
pmid:1373535
|
Hirano Y et al. |
Morphological and functional changes of islets of Langerhans in FK506-treated rats. |
1992 |
Transplantation |
pmid:1373536
|
Chen TS et al. |
Microbial transformation of immunosuppressive compounds. II. Specific desmethylation of 13-methoxy group of FK 506 and FR 900520 by an unidentified Actinomycete ATCC 53828 [corrected]. |
1992 |
J. Antibiot. |
pmid:1375593
|
Meingassner JG and Stütz A |
Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases? |
1992 |
J. Invest. Dermatol. |
pmid:1375617
|
Schneck FX et al. |
Pediatric renal transplantation under FK-506 immunosuppression. |
1992 |
J. Urol. |
pmid:1375663
|
Connelly PR and Thomson JA |
Heat capacity changes and hydrophobic interactions in the binding of FK506 and rapamycin to the FK506 binding protein. |
1992 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:1375751
|
Lancaster JR et al. |
EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. |
1992 |
J. Biol. Chem. |
pmid:1375934
|
Hirai T et al. |
The immunosuppressive effect of FK 506 on canine lung transplantation. |
1992 |
J. Thorac. Cardiovasc. Surg. |
pmid:1375967
|
de Paulis A et al. |
Anti-inflammatory effect of FK-506 on human skin mast cells. |
1992 |
J. Invest. Dermatol. |
pmid:1281861
|
O'Keefe SJ et al. |
FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. |
1992 |
Nature |
pmid:1377361
|
Clipstone NA and Crabtree GR |
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. |
1992 |
Nature |
pmid:1377362
|
Hasegawa S et al. |
Combination use of suboptimal dose of FK 506 and cyclosporine in canine lung transplantation. |
1992 |
J. Thorac. Cardiovasc. Surg. |
pmid:1279319
|
Peattie DA et al. |
Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes. |
1992 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:1279700
|
Lhoëst G et al. |
Isolation and mass spectrometric identification of two metabolites of FK 506 from rat liver microsomal incubation media. |
1992 |
Pharm Acta Helv |
pmid:1279730
|
Benigni A et al. |
The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance. |
1992 |
Transplantation |
pmid:1279848
|
Minoda M et al. |
Effects of gamma-interferon and FK506 on resting B cell proliferation of New Zealand black/white F1 mice. |
1992 |
Microbiol. Immunol. |
pmid:1282197
|
Min DI et al. |
Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection. |
1992 |
Am J Hosp Pharm |
pmid:1282779
|
Mochizuki M |
[Immunotherapy in ocular diseases]. |
1992 |
Nippon Ganka Gakkai Zasshi |
pmid:1283052
|
Olejniczak ET et al. |
A 4D HCCH-TOCSY experiment for assigning the side chain 1H and 13C resonances of proteins. |
1992 |
J. Biomol. NMR |
pmid:1283353
|
Bauer S et al. |
The effect of the new immunosuppressive drug FK506 on the formation of secondary metabolites of cyclosporin A. |
1992 |
Int J Clin Pharmacol Ther Toxicol |
pmid:1283385
|
Renoir JM et al. |
[Effect of immunosuppressants FK506 and rapamycin on the function of progesterone receptor: protein "p59-HBI", intersection between immunology and endocrinology?]. |
1992 |
C. R. Acad. Sci. III, Sci. Vie |
pmid:1284044
|
First MR |
Renal transplantation for the nephrologist: new immunosuppressive drugs. |
1992 |
Am. J. Kidney Dis. |
pmid:1371201
|
Fukuse T et al. |
Optimal dose of FK 506 in canine lung allotransplantation. |
1992 |
Transplant. Proc. |
pmid:1379757
|
Wada H et al. |
Combination use of suboptimal doses of FK 506 and cyclosporine in canine lung transplantation. |
1992 |
Transplant. Proc. |
pmid:1379758
|
Cai X et al. |
Low-dose of FK 506 and associated blood levels in allotransplantation of rat liver, heart, and skin. |
1992 |
Transplant. Proc. |
pmid:1379759
|
Taki J et al. |
DNA analysis of peripheral blood mononuclear cells for early detection of hepatic graft rejection. |
1992 |
Transplant. Proc. |
pmid:1379760
|
Sato Y et al. |
FK 506 suppresses class II antigen expression in regenerating livers following partial hepatectomy in the rat. |
1992 |
Transplant. Proc. |
pmid:1379761
|
Stütz A |
Immunosuppressive macrolides. |
1992 |
Transplant. Proc. |
pmid:1379762
|
Leiva MC and Lyttle CR |
Leukocyte chemotactic activity of FKBP and inhibition by FK506. |
1992 |
Biochem. Biophys. Res. Commun. |
pmid:1379802
|
Arceci RJ et al. |
Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype. |
1992 |
Blood |
pmid:1381629
|
Pahl A and Keller U |
FK-506-binding proteins from streptomycetes producing immunosuppressive macrolactones of the FK-506 type. |
1992 |
J. Bacteriol. |
pmid:1381710
|
Takahashi N |
[Cyclophilin and FK506-binding protein]. |
1992 |
Seikagaku |
pmid:1381737
|
Lee TK et al. |
Mucosal glutamine utilization after small-bowel transplantation: an electrophysiologic study. |
1992 |
J. Surg. Res. |
pmid:1382152
|
Kaye RE et al. |
Effects of cyclosporin A and FK506 on Fc epsilon receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12. |
1992 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:1382293
|
Edalji R et al. |
High-level expression of recombinant human FK-binding protein from a fusion precursor. |
1992 |
J. Protein Chem. |
pmid:1382438
|
Chung J et al. |
Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. |
1992 |
Cell |
pmid:1377606
|
Xu RX et al. |
Stereospecific assignments and chi 1 rotamers for FKBP when bound to ascomycin from 3JH alpha,H beta and 3HN,H beta coupling constants. |
1992 |
FEBS Lett. |
pmid:1377648
|
Petros AM et al. |
NMR studies of an FK-506 analog, [U-13C]ascomycin, bound to FK-506-binding protein. |
1992 |
J. Med. Chem. |
pmid:1377749
|
Strom TB |
Molecular immunology and immunopharmacology of allograft rejection. |
1992 |
Kidney Int. Suppl. |
pmid:1383599
|